Wed Mar 30 Clarity's US-based Cu-64 SAR-bisPSMA trial in prostate cancer opens for recruitment Written by PR Newswire Asia - News Pronto RSS Share to wechat： Read more https://www.prnasia.com/story/archive/3705006_CN05006_0
